Article
Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
9 Mar 2021
Abstract excerpt
Castration-resistant prostate cancer (CRPC) almost invariably occurs after androgen-deprivation therapy (ADT) for the advanced metastatic disease. It is generally believed that among multiple mechanisms and signaling pathways, CRPC is significantly driven by the reactivation of androgen receptor (AR) signaling in ADT-treated patients with castrate levels of androgen, partially at least mediated by the androgen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
